12.35
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register
Assembly Biosciences Reports Q1 2025 Earnings - TipRanks
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast - GuruFocus
Assembly Biosciences Updates on Clinical Progress and Financials, Anticipates Key Data in 2025 - Nasdaq
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences (ASMB) Highlights Promising Preclinical Data at EASL Congress | ASMB Stock News - GuruFocus
New Preclinical Data for Assembly Biosciences' Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025 - The Manila Times
Ribbon Bio Launches MiroSynth™ DNA Molecules to Unlock a New Era of Complex Synthetic DNA - Yahoo Finance
Raymond James Financial Inc. Invests $973,000 in Invesco 0-5 Yr US TIPS ETF (BATS:PBTP) - The AM Reporter
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock? - NewsBreak: Local News & Alerts
Learn to Evaluate (ASMB) using the Charts - news.stocktradersdaily.com
JPMorgan Chase & Co. Acquires 7,918 Shares of Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Assembly Biosciences Insiders Added US$679.4k Of Stock To Their Holdings - simplywall.st
Assembly Biosciences (NASDAQ:ASMB) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Renaissance Technologies LLC Boosts Stock Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Long Term Trading Analysis for (ASMB) - news.stocktradersdaily.com
Assembly Biosciences director sells $7,455 in stock - Investing.com Australia
Assembly Biosciences director sells $7,455 in stock By Investing.com - Investing.com South Africa
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight - PR Newswire UK
Assembly Biosciences Presents New Data Highlighting Long-Acting - GuruFocus
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress - The Manila Times
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround - Yahoo Finance
ASMB stock touches 52-week low at $8.21 amid market challenges - Investing.com
ASMB stock touches 52-week low at $8.21 amid market challenges By Investing.com - Investing.com South Africa
Mastercard Is Taking On the World and Winning - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough - simplywall.st
(ASMB) Investment Report - news.stocktradersdaily.com
Consumer Internet Stocks Q4 Teardown: Remitly (NASDAQ:RELY) Vs The Rest - The Globe and Mail
Assembly Biosciences CEO sells shares worth $3,496 By Investing.com - Investing.com Canada
Assembly Biosciences officer sells $1,772 in stock By Investing.com - Investing.com South Africa
Assembly Biosciences CEO sells shares worth $3,496 - Investing.com
Assembly Biosciences officer sells shares for $1,940 - Investing.com India
Assembly Biosciences officer sells $1,772 in stock - Investing.com India
Five9 (FIVN): Buy, Sell, or Hold Post Q4 Earnings? - The Globe and Mail
ASMB stock touches 52-week low at $10.1 amid market challenges - Investing.com
Q4 Earnings Outperformers: Fastenal (NASDAQ:FAST) And The Rest Of The Maintenance and Repair Distributors Stocks - The Globe and Mail
Assembly Biosciences (ASMB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Research Analysts Offer Predictions for ASMB Q1 Earnings - Defense World
Guggenheim Initiates Coverage of Assembly Biosciences (ASMB) with Buy Recommendation - MSN
Research Analysts Issue Forecasts for ASMB FY2029 Earnings - Defense World
Assembly Biosciences (NASDAQ:ASMB) Now Covered by Guggenheim - Defense World
Assembly Biosciences Reports 2024 Financial Results and Progress - TipRanks
This Clearway Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):